278 related articles for article (PubMed ID: 30106435)
21. 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Promotes Phenotypic Switching from Dedifferentiated to Differentiated Phenotype via Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase in Vascular Smooth Muscle Cells.
Dan J; Sun X; Li W; Zhang Y; Li X; Xu H; Li Z; Tian Z; Guo S; Yao J; Gao W; Tian Y
Ultrasound Med Biol; 2015 Jun; 41(6):1681-9. PubMed ID: 25796412
[TBL] [Abstract][Full Text] [Related]
22. Sinoporphyrin Sodium-Mediated Sonodynamic Therapy Inhibits RIP3 Expression and Induces Apoptosis in the H446 Small Cell Lung Cancer Cell Line.
Shen J; Cao S; Sun X; Pan B; Cao J; Che D; Jin S; Cao Y; Tian Y; Yu Y
Cell Physiol Biochem; 2018; 51(6):2938-2954. PubMed ID: 30562734
[TBL] [Abstract][Full Text] [Related]
23. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer.
Tsuru H; Shibaguchi H; Kuroki M; Yamashita Y; Kuroki M
Free Radic Biol Med; 2012 Aug; 53(3):464-72. PubMed ID: 22588110
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W
Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978
[TBL] [Abstract][Full Text] [Related]
25. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
Zhu P; Chen Y; Shi J
ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
[TBL] [Abstract][Full Text] [Related]
26. Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.
Mattarollo SR; Steegh K; Li M; Duret H; Foong Ngiow S; Smyth MJ
Immunol Cell Biol; 2013 Jan; 91(1):105-14. PubMed ID: 23090488
[TBL] [Abstract][Full Text] [Related]
27. 5-aminolevulinic acid sonodynamic therapy for cutaneous squamous cell carcinoma.
Li C; Yan J; Wang P; Zhang H; Zeng Q; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103801. PubMed ID: 37717674
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
29. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
[No Abstract] [Full Text] [Related]
30. Ultrasound activation of TiO2 in melanoma tumors.
Harada Y; Ogawa K; Irie Y; Endo H; Feril LB; Uemura T; Tachibana K
J Control Release; 2011 Jan; 149(2):190-5. PubMed ID: 20951750
[TBL] [Abstract][Full Text] [Related]
31. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
[TBL] [Abstract][Full Text] [Related]
32. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
34. Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.
Xu M; Xing Y; Zhou L; Yang X; Yao W; Xiao W; Ge C; Ma Y; Yang J; Wu J; Cao R; Li T; Liu J
Tumour Biol; 2013 Jun; 34(3):1399-408. PubMed ID: 23456765
[TBL] [Abstract][Full Text] [Related]
35. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4
He K; Liu P; Xu LX
Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145
[TBL] [Abstract][Full Text] [Related]
36. Artesunate Enhances the Cytotoxicity of 5-Aminolevulinic Acid-Based Sonodynamic Therapy against Mouse Mammary Tumor Cells In Vitro.
Osaki T; Uto Y; Ishizuka M; Tanaka T; Yamanaka N; Kurahashi T; Azuma K; Murahata Y; Tsuka T; Itoh N; Imagawa T; Okamoto Y
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346389
[TBL] [Abstract][Full Text] [Related]
37. Anti-VEGF Treatment Enhances CD8
de Almeida PE; Mak J; Hernandez G; Jesudason R; Herault A; Javinal V; Borneo J; Kim JM; Walsh KB
Cancer Immunol Res; 2020 Jun; 8(6):806-818. PubMed ID: 32238381
[TBL] [Abstract][Full Text] [Related]
38. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis.
Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX
Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
40. Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice.
Ahern E; Harjunpää H; Barkauskas D; Allen S; Takeda K; Yagita H; Wyld D; Dougall WC; Teng MWL; Smyth MJ
Clin Cancer Res; 2017 Oct; 23(19):5789-5801. PubMed ID: 28634284
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
